Projects:Utah2ShapeRegression - Revision history

JChris.FillionR: Fix MediaWiki formatting issue discovered while converting to GitHub Flavored Markdown using pandoc (via https://github.com/outofcontrol/mediawiki-to-gfm)

2023-04-11T20:44:44Z

Fix MediaWiki formatting issue discovered while converting to GitHub Flavored Markdown using pandoc (via https://github.com/outofcontrol/mediawiki-to-gfm)

Jfishbaugh at 21:59, 16 August 2012

2012-08-16T21:59:20Z

Jfishbaugh at 01:48, 29 September 2011

2011-09-29T01:48:34Z

Jfishbaugh at 01:48, 29 September 2011

2011-09-29T01:48:06Z

Jfishbaugh at 00:53, 29 September 2011

2011-09-29T00:53:48Z

Jfishbaugh at 00:52, 29 September 2011

2011-09-29T00:52:43Z

Jfishbaugh at 00:48, 29 September 2011

2011-09-29T00:48:31Z

Jfishbaugh at 00:45, 29 September 2011

2011-09-29T00:45:33Z

Jfishbaugh at 00:45, 29 September 2011

2011-09-29T00:45:14Z

Jfishbaugh at 00:43, 29 September 2011

2011-09-29T00:43:41Z

@@ Line 91: / Line 91: @@
 {| border="0" style="background:transparent;"
-[[File:VentShape-Regression-Movie.gif|700px|thumb|left| Shape regression for individual subject from 6 months to 2 years.  [[Media:VentShape-Regression-Movie.gif|Click here for full size.]] ]]
+| [[File:VentShape-Regression-Movie.gif|700px|thumb|left| Shape regression for individual subject from 6 months to 2 years.  [[Media:VentShape-Regression-Movie.gif|Click here for full size.]] ]]
 |-
 |}

@@ Line 2: / Line 2: @@
 __NOTOC__
-= Ongoing Work (Updated 9/28/11) =
+= Ongoing Work (Updated 8/16/12) =
 == Smooth Growth Trajectories from Time Series Shape Data ==
@@ Line 52: / Line 52: @@
 [[Image:Volume_sigmaV_10_sigmaW_10_gammaR_0p1.png|thumb|500px|center| Volume measured after shape regression.  Plus signs denote target volume.]]
 = Former Work =

@@ Line 37: / Line 37: @@
 [[File:Leave_several_out_summary.png|600px|center|thumb|'''Left:''' Snapshots from a continuous shape evolution of lateral ventricles estimated by our regression model.  Acceleration vectors are displayed on the surface, with color denoting magnitude. '''Right:''' The impact of the number of target shapes on R^2.]]
-== Application to Autism (former DBP partner UNC Psychiatry) ==
+== Application to Autism Research (former DBP partner UNC Psychiatry) ==
 Preliminary results seem to indicate a different pattern of growth between the HR+ group (high risk diagnosed with Autism or ASD) and the HR- (high risk not diagnosed with Autism) and LR- (controls not diagnosed with Autism) groups.  We observe rapid outward growth of the forebrain in HR+, as compared to more isotropic growth in HR- and LR-.  Currently we are working on developing a complete statistical framework for the analysis of shape trajectories as well as the evolution of scalar measurements derived from shape (such as volume or circumference).

@@ Line 37: / Line 37: @@
 [[File:Leave_several_out_summary.png|600px|center|thumb|'''Left:''' Snapshots from a continuous shape evolution of lateral ventricles estimated by our regression model.  Acceleration vectors are displayed on the surface, with color denoting magnitude. '''Right:''' The impact of the number of target shapes on R^2.]]
-== Application to Autism ==
+== Application to Autism (former DBP partner UNC Psychiatry) ==
 Preliminary results seem to indicate a different pattern of growth between the HR+ group (high risk diagnosed with Autism or ASD) and the HR- (high risk not diagnosed with Autism) and LR- (controls not diagnosed with Autism) groups.  We observe rapid outward growth of the forebrain in HR+, as compared to more isotropic growth in HR- and LR-.  Currently we are working on developing a complete statistical framework for the analysis of shape trajectories as well as the evolution of scalar measurements derived from shape (such as volume or circumference).
@@ Line 45: / Line 45: @@
 [[File:Mean_scenarios_volume_and_circumference.png|800px|center|thumb|Volume and circumference measured from mean growth scenarios.]]
-== Application to Huntington's Disease ==
+== Application to Huntington's Disease (DBP partner Iowa) ==
 We are investigating the application of our shape regression framework to the study of Huntington's disease.  Here we estimate the evolution of a shape complex consisting of 6 sets of sub-cortical structures (12 total shapes).  We observe a volume loss over time in all the structures except the ventricles, which are expected to grow if the other structures shrink (they are fluid).  These preliminary results on a single subject are promising, and we are beginning to experiment on many additional subjects.

@@ Line 47: / Line 47: @@
 == Application to Huntington's Disease ==
-We are investigating the application of our shape regression framework to the study of Huntington's disease.  Here we estimate the evolution of a shape complex consisting of 6 sets of sub-cortical structures (12 total shapes).  We observe a volume loss over time in all the structures except the ventricles, which are expected to grow if the other structures shrink.  These preliminary results on a single subject are promising, and we are beginning to experiment on many additional subjects.
+We are investigating the application of our shape regression framework to the study of Huntington's disease.  Here we estimate the evolution of a shape complex consisting of 6 sets of sub-cortical structures (12 total shapes).  We observe a volume loss over time in all the structures except the ventricles, which are expected to grow if the other structures shrink (they are fluid).  These preliminary results on a single subject are promising, and we are beginning to experiment on many additional subjects.
 [[Image:Sub_cort_evo_snapshot.png|thumb|800px|center| Snapshots of the evolution of several sub-cortical structures.  Color denotes magnitude of velocity.  [[Media:Sub_cort_evolution_sigmaV_10_sigmaW_10_gammaR_0p1.gif|Click here for an animation.]] ]]

← Older revision		Revision as of 00:52, 29 September 2011
Line 46:		Line 46:

	== Application to Huntington's Disease ==		== Application to Huntington's Disease ==
		+
		+	We are investigating the application of our shape regression framework to the study of Huntington's disease. Here we estimate the evolution of a shape complex consisting of 6 sets of sub-cortical structures (12 total shapes). We observe a volume loss over time in all the structures except the ventricles, which are expected to grow if the other structures shrink. These preliminary results on a single subject are promising, and we are beginning to experiment on many additional subjects.

	[[Image:Sub_cort_evo_snapshot.png\|thumb\|800px\|center\| Snapshots of the evolution of several sub-cortical structures. Color denotes magnitude of velocity. [[Media:Sub_cort_evolution_sigmaV_10_sigmaW_10_gammaR_0p1.gif\|Click here for an animation.]] ]]		[[Image:Sub_cort_evo_snapshot.png\|thumb\|800px\|center\| Snapshots of the evolution of several sub-cortical structures. Color denotes magnitude of velocity. [[Media:Sub_cort_evolution_sigmaV_10_sigmaW_10_gammaR_0p1.gif\|Click here for an animation.]] ]]

← Older revision		Revision as of 00:48, 29 September 2011
Line 46:		Line 46:

	== Application to Huntington's Disease ==		== Application to Huntington's Disease ==
		+
		+	[[Image:Sub_cort_evo_snapshot.png\|thumb\|800px\|center\| Snapshots of the evolution of several sub-cortical structures. Color denotes magnitude of velocity. [[Media:Sub_cort_evolution_sigmaV_10_sigmaW_10_gammaR_0p1.gif\|Click here for an animation.]] ]]
		+
		+	[[Image:Volume_sigmaV_10_sigmaW_10_gammaR_0p1.png\|thumb\|500px\|center\| Volume measured after shape regression. Plus signs denote target volume.]]

	= Former Work =		= Former Work =

@@ Line 43: / Line 43: @@
 [[File:Hrp_hrm_lrm_mean_scenario_small_first_frame.png|800px|center|thumb|Mean growth scenarios for HR+ (high risk diagnosed with Autism or ASD), HR- (high risk not diagnosed with Autism), and LR- (controls not diagnosed with Autism).  [[Media:Hrp_hrm_lrm_mean_scenario_small.gif|Click here for an animation.]] ]]
-[[File:Mean_scenarios_volume_and_circumference.png|600px|center|thumb|Volume and circumference measured from mean growth scenarios.]]
+[[File:Mean_scenarios_volume_and_circumference.png|800px|center|thumb|Volume and circumference measured from mean growth scenarios.]]
 == Application to Huntington's Disease ==

← Older revision		Revision as of 00:45, 29 September 2011
Line 42:		Line 42:

	[[File:Hrp_hrm_lrm_mean_scenario_small_first_frame.png\|800px\|center\|thumb\|Mean growth scenarios for HR+ (high risk diagnosed with Autism or ASD), HR- (high risk not diagnosed with Autism), and LR- (controls not diagnosed with Autism). [[Media:Hrp_hrm_lrm_mean_scenario_small.gif\|Click here for an animation.]] ]]		[[File:Hrp_hrm_lrm_mean_scenario_small_first_frame.png\|800px\|center\|thumb\|Mean growth scenarios for HR+ (high risk diagnosed with Autism or ASD), HR- (high risk not diagnosed with Autism), and LR- (controls not diagnosed with Autism). [[Media:Hrp_hrm_lrm_mean_scenario_small.gif\|Click here for an animation.]] ]]
		+
		+	[[File:Mean_scenarios_volume_and_circumference.png\|600px\|center\|thumb\|Volume and circumference measured from mean growth scenarios.]]

	== Application to Huntington's Disease ==		== Application to Huntington's Disease ==